| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.10▼ | 1.10▼ | 1.11▼ | 1.20▼ | 1.20▼ |
| MA10 | 1.10▼ | 1.11▼ | 1.16▼ | 1.21▼ | 1.23▼ |
| MA20 | 1.10▼ | 1.17▼ | 1.20▼ | 1.22▼ | 1.50▼ |
| MA50 | 1.16▼ | 1.22▼ | 1.23▼ | 1.25▼ | 3.06▼ |
| MA100 | 1.21▼ | 1.21▼ | 1.22▼ | 1.55▼ | 8.17▼ |
| MA200 | 1.21▼ | 1.23▼ | 1.24▼ | 2.37▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | -0.006▼ | -0.014▼ | -0.001▼ | 0.138▲ |
| RSI | 39.375▼ | 33.484▼ | 26.970▼ | 32.412▼ | 32.087▼ |
| STOCH | 30.000 | 39.884 | 37.324 | 57.229 | 20.176 |
| WILL %R | -80.000▼ | -71.053 | -72.500 | -78.846▼ | -96.405▼ |
| CCI | -100.000▼ | -66.228 | -107.115▼ | -199.418▼ | -88.518 |
| ▼ MACD | $ICU MACD(12,26,9) Crossed Below Signal Line | Set Alert |
| ▼ GAP | $ICU Open Gap Down %5 | Set Alert |
| ▼ GAP | $ICU Open Gap Down %3 | Set Alert |
| ▼ GAP | $ICU Open Gap Down %2 | Set Alert |
| ▼ BREAK | $ICU Price Breaks 60 Days Low | Set Alert |
| ▼ BREAK | $ICU Price Breaks 30 Days Low | Set Alert |
| ▼ BREAK | $ICU Price Breaks 20 Days Low | Set Alert |
| ▼ BREAK | $ICU Price Breaks 10 Days Low | Set Alert |
|
Friday, June 13, 2025 04:27 AM
Teleflex reports new findings from a study showing the efficacy of its Arrow chlorhexidine-impregnated central venous catheters (CVCs).
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 16/06/25 | 1.04 | 1.14 | 1.04 | 1.095 | 291,106 |
| 13/06/25 | 1.21 | 1.25 | 1.15 | 1.18 | 165,792 |
| 12/06/25 | 1.26 | 1.26 | 1.21 | 1.24 | 96,652 |
| 11/06/25 | 1.26 | 1.2899 | 1.22 | 1.24 | 346,757 |
| 10/06/25 | 1.26 | 1.275 | 1.24 | 1.25 | 91,366 |
| 09/06/25 | 1.29 | 1.30 | 1.25 | 1.27 | 165,398 |
| 06/06/25 | 1.20 | 1.27 | 1.18 | 1.27 | 149,549 |
| 05/06/25 | 1.21 | 1.21 | 1.1745 | 1.192 | 91,237 |
| 04/06/25 | 1.16 | 1.21 | 1.1555 | 1.21 | 90,564 |
| 03/06/25 | 1.17 | 1.1964 | 1.12 | 1.15 | 137,586 |
|
|
||||
|
|
||||
|
|